Resultados de la búsqueda 111-120 of 5030 for 구글찌라시 ⌚ 12242333 ⌚텔@adtopking⌚⌚SEO대행⌚⌚⌚텔@adtopking⌚⌚⌚SEO툴⌚⌚⌚

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This resource-platform will be named Project BTTRFLY (Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young). A Study to Evaluate Screening ...

  2. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...

  6. Noticias - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

    News · mayo 2025 · enero 2025 · diciembre 2024 · noviembre 2024 · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024.

  7. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to: Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is for IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...